HCLFoundation, which drives the corporate social responsibility agenda of global technology company HCLTech in India, has announced the winner NGOs of the 2024 edition of its flagship program, the HCLTech Grant in rural India's
Doctors at HCG Cancer Hospital have discovered a potential new cause of oral submucosal fibrosis (OSMF). This cancer causes oral tissues to thicken and restrict the opening of the mouth. Fluoride in gutkha
GSK plc announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, announced positive findings from its phase I study showing that an investigational formulation
Sanskritech, a health-tech company in India backed by Mylab, has launched Swandook, an ultra-smart anytime health monitoring bag. Approved by CDSCO, Swandook represents a pioneering leap in healthcare technology, said the company
Cynata Therapeutics Limited, a clinical-stage biotechnology company specializing in cell therapeutics, confirms that the first patient has been enrolled and treated in its phase 2 clinical trial of CYP-001 in high-risk acute graft versus
The owner of Sudeep Pharma is in talks with Avendus Capital to secure ₹800 crore in debt to buy out its joint venture partner, German manufacturer JRS Pharma, and take full ownership of the pharmaceutical company.
The Subject Expert Committee (SEC), which advises the national drug regulator on drug approvals and clinical trials, has recommended the grant of permission to drug major AstraZeneca for the import and marketing of two strengths of anti-hyperkalemia
Roche Pharma India has Introduced Vabysmo (faricimab) in the Indian market. This monoclonal immune response drug targets two critical reasons for vision impairment among the old and diabetic patients. In a proclamation...
Caliway Biopharmaceuticals declared that the US Food and Medication Organization (FDA) permitted Orphan Drug Designation (ODD) to CBL-514 for Dercum's illness treatment. CBL-514 is a lipolysis injection that can diminish nearby subcutaneous fat...
Sandoz, the leader in conventional and biosimilar drugs, has acquired the US biosimilar Cimerli (ranibizumab-eqrn) from Coherus BioSciences, Inc., before expected timetables. The procurement expands on the main Sandoz ophthalmic stage in the US...
, CDSCO.jpg)
